<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: It was recently reported that serum <z:chebi fb="1" ids="50211">retinol</z:chebi>-binding protein (RBP), also known as <z:chebi fb="1" ids="50211">retinol</z:chebi>-binding protein 4 (RBP4), was positively associated with systemic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that an imbalance between RBP and <z:chebi fb="1" ids="50211">retinol</z:chebi> might be the underlying cause for this association </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We studied the ratio between RBP and <z:chebi fb="1" ids="50211">retinol</z:chebi> in 233 humans divided into groups depending on <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT), <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT), type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (T2DM) and presence or absence of <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Plasma RBP and <z:chebi fb="1" ids="50211">retinol</z:chebi> levels were lower in patients with T2DM than in individuals with NGT (p &lt; 0.05 and p &lt; 0.0001 respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, RBP-to-<z:chebi fb="1" ids="50211">retinol</z:chebi> ratio was higher in individuals with T2DM (p &lt; 0.0001) and IGT (p &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Following multivariate adjustment, RBP and <z:chebi fb="1" ids="50211">retinol</z:chebi> correlated positively with <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (p &lt; 0.0001, except <z:chebi fb="1" ids="50211">retinol</z:chebi> and <z:chebi fb="15" ids="39026">LDL</z:chebi>: p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>RBP-to-<z:chebi fb="1" ids="50211">retinol</z:chebi> ratio correlated positively with <z:chebi fb="105" ids="17234">glucose</z:chebi> 2 h after an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (p &lt; 0.0001) and with C-reactive protein (p &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="1" ids="50211">Retinol</z:chebi>, RBP and adipose tissue RBP <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) levels shared an inverse relationship with plasma interleukin-6, and adipose tissue RBP <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels correlated positively with plasma <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) and skeletal muscle TNF-alpha <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Our results suggest that the excess of RBP relative to <z:chebi fb="1" ids="50211">retinol</z:chebi>, assessed as the RBP-to-<z:chebi fb="1" ids="50211">retinol</z:chebi> ratio, is more indicative of T2DM than RBP itself </plain></SENT>
<SENT sid="9" pm="."><plain>Hence, the previously reported <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in mice induced by overexpression or injection of RBP could be because of higher levels of RBP relative to <z:chebi fb="1" ids="50211">retinol</z:chebi> rather than higher total levels of RBP </plain></SENT>
<SENT sid="10" pm="."><plain>Moreover, TNF-alpha may have a role in RBP-mediated adipose to muscle crosstalk </plain></SENT>
</text></document>